| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Eagle Pharmaceuticals Inc (NASDAQ: EGRX)
EGRX Technical Analysis
3
| As on 7th Nov 2025 EGRX STOCK Price closed @ 1.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.13 & Buy for SHORT-TERM with Stoploss of 1.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EGRXSTOCK Price
| Open | 1.50 | Change | Price | % |
| High | 1.50 | 1 Day | 0.75 | 100.00 |
| Low | 1.50 | 1 Week | 1.40 | 1400.00 |
| Close | 1.50 | 1 Month | -1.65 | -52.38 |
| Volume | 100 | 1 Year | 0.86 | 134.38 |
| 52 Week High 3.75 | 52 Week Low 0.10 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| IRBT | 3.69 | 21.78% |
| NVDA | 182.41 | -0.53% |
| SOFI | 27.78 | -6.15% |
| NFLX | 100.24 | -2.89% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| BYND | 1.22 | -1.61% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EGRX Daily Charts |
EGRX Intraday Charts |
Whats New @ Bazaartrend |
EGRX Free Analysis |
|
|
EGRX Important Levels Intraday
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
| RESISTANCE | 1.50 |
EGRX Forecast December 2025
| 4th UP Forecast | 4.37 |
| 3rd UP Forecast | 3.45 |
| 2nd UP Forecast | 2.88 |
| 1st UP Forecast | 2.31 |
| 1st DOWN Forecast | 0.69 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | -0.45 |
| 4th DOWN Forecast | -1.37 |
EGRX Weekly Forecast
| 4th UP Forecast | 3.41 |
| 3rd UP Forecast | 2.80 |
| 2nd UP Forecast | 2.42 |
| 1st UP Forecast | 2.04 |
| 1st DOWN Forecast | 0.96 |
| 2nd DOWN Forecast | 0.58 |
| 3rd DOWN Forecast | 0.20 |
| 4th DOWN Forecast | -0.41 |
EGRX Forecast2025
| 4th UP Forecast | 8.76 |
| 3rd UP Forecast | 6.43 |
| 2nd UP Forecast | 4.99 |
| 1st UP Forecast | 3.55 |
| 1st DOWN Forecast | -0.55 |
| 2nd DOWN Forecast | -1.99 |
| 3rd DOWN Forecast | -3.43 |
| 4th DOWN Forecast | -5.76 |
Eagle Pharmaceuticals Inc ( NASDAQ USA Symbol : EGRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EGRX Business Profile
Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke, as well as to treat organophosphate exposure; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey. Address: 50 Tice Boulevard, Woodcliff Lake, NJ, United States, 07677
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service